Nanobiotix (NASDAQ:NBTX) Shares Gap Down – Time to Sell?

Shares of Nanobiotix S.A. – Sponsored ADR (NASDAQ:NBTX) gapped down prior to trading on Thursday. The stock had previously closed at $31.16, but opened at $29.99. Nanobiotix shares last traded at $29.8790, with a volume of 9,803 shares traded.

Wall Street Analyst Weigh In

NBTX has been the topic of a number of research reports. Guggenheim started coverage on shares of Nanobiotix in a research report on Tuesday, September 15th. They set a “buy” rating and a $64.00 target price on the stock. Leerink Partners boosted their price target on shares of Nanobiotix from $37.00 to $46.00 and gave the stock an “outperform” rating in a research note on Thursday, June 4th. Finally, Weiss Ratings restated a “sell (d-)” rating on shares of Nanobiotix in a report on Friday, July 17th. Four research analysts have rated the stock with a Buy rating, one has issued a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average price target of $46.67.

Nanobiotix Trading Down 8.3%

The stock has a fifty day moving average of $38.32 and a 200-day moving average of $37.29.

Nanobiotix Company Profile

Nanobiotix is a clinical-stage biotechnology company focused on developing nanomedicine-based therapies for cancer. The company’s technology is designed to improve the effectiveness of radiotherapy by using nanoparticles that interact with radiation inside tumors, with the goal of enhancing tumor-cell destruction while limiting damage to surrounding healthy tissue.

Its lead product candidate, NBTXR3, is an investigational radioenhancer consisting of functionalized hafnium oxide nanoparticles.